Genitourinary cancers are found in urinary tract (kidney and bladder) and male reproductive system (prostate, testicles and penis).
The Genitourinary (GU) Oncology Service at Peter Mac specialises in cancers arising from the urinary tract and male reproductive system. This includes cancers of the prostate, bladder, kidney, ureter, penis and testis.
Our multidisciplinary team includes urologists, medical oncologists, radiation oncologists, nurses, psychologists and other healthcare professionals, all working together to provide world class cancer care to patients with GU cancers. Our clinicians are all highly academic with extensive interests in research, education and training in all aspects of cancer care.
For prostate cancer patients, we offer active surveillance, robotic surgery, low and high dose rate brachytherapy, image-guided radiotherapy, stereotactic radiotherapy (SABR), chemotherapy, targeted therapies and a large array of clinical trials. This fully comprehensive approach is unique within the public health system in Australia and our team are very experienced in all of these approaches.
Similarly we provide a comprehensive range of patient-focussed management options with cancers arising from the kidney, ureter, bladder, penis and testis, and have research programs in all of these areas. We work closely with our nursing and allied health colleagues to best support our patients along their cancer surgery.
The Director of GU Oncology is Consultant Urologist at Peter Mac, Associate Professor Declan Murphy.
Activities in the GU Oncology Service include:
- Prompt access for new patients to our multidisciplinary team
- Full diagnostic facilities in our state-of-the-art $1bn cancer centre
- Robotic surgery for GU cancers including prostate and kidney
- Transperineal prostate biopsy
- LDR and HDR brachytherapy
- Stereotactic radiotherapy
- Highly specialised cancer imaging including CT, PET/CT and MRI
- Very active clinical trials program,
- Tertiary referrals and second opinions welcome
- Weekly multidisciplinary team meetings
- Prolific research and education program
- Internationally recognised Fellowship training in GU Oncoogy
Find out more about our Radiation Therapy service.
As with all Peter Mac’s tumour streams, the Genitourinary (GU) Oncology Service provides integrated cancer care across the precinct as part of a single tumour stream involving Peter Mac, the Royal Melbourne Hospital, and the Royal Women’s Hospital.
We provide three GU Oncology multidisciplinary clinics per week.
We have a comprehensive clinical trials portfolio in GU Oncology, prostate cancer in particular. Our clinical trials program is led by Dr Ben Tran, Medical Oncologist, and offers a wide range of advanced research options for many of our patients.
Every cancer patient is at the heart of what we do. Dedicated to you, we commit and pursue state-of-the-art research that we link from bench to bedside and beyond.
If you would like to participate or have questions about clinical trials, speak to your specialist.
Find out more about participating in clinical research at Peter Mac.
We understand how stressful and difficult a diagnosis of cancer can be.
Your Peter Mac team of experts are dedicated and sensitive to your individual health and wellbeing needs – we are here to help.
Please ask your GP or specialist to refer you to our GU Oncology team. The majority of our referrals are second opinions and we accept patients from all over Australia.
New patients are typically seen within one to two weeks.
For health professionals
Referrals are welcome from general practitioners and other specialists, and new patients are typically seen within one to two weeks.
Visit the referrals page for further information.